These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 27409479)

  • 1. En Face Spectral-Domain Optical Coherence Tomography for the Monitoring of Lesion Area Progression in Stargardt Disease.
    Melillo P; Testa F; Rossi S; Di Iorio V; Orrico A; Auricchio A; Simonelli F
    Invest Ophthalmol Vis Sci; 2016 Jul; 57(9):OCT247-52. PubMed ID: 27409479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The absence of fundus abnormalities in Stargardt disease.
    Bax NM; Lambertus S; Cremers FPM; Klevering BJ; Hoyng CB
    Graefes Arch Clin Exp Ophthalmol; 2019 Jun; 257(6):1147-1157. PubMed ID: 30903310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multimodal analysis of the Preferred Retinal Location and the Transition Zone in patients with Stargardt Disease.
    Verdina T; Greenstein VC; Sodi A; Tsang SH; Burke TR; Passerini I; Allikmets R; Virgili G; Cavallini GM; Rizzo S
    Graefes Arch Clin Exp Ophthalmol; 2017 Jul; 255(7):1307-1317. PubMed ID: 28365912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantifying the Rate of Ellipsoid Zone Loss in Stargardt Disease.
    Cai CX; Light JG; Handa JT
    Am J Ophthalmol; 2018 Feb; 186():1-9. PubMed ID: 29126757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macular Sensitivity Measured With Microperimetry in Stargardt Disease in the Progression of Atrophy Secondary to Stargardt Disease (ProgStar) Study: Report No. 7.
    Schönbach EM; Wolfson Y; Strauss RW; Ibrahim MA; Kong X; Muñoz B; Birch DG; Cideciyan AV; Hahn GA; Nittala M; Sunness JS; Sadda SR; West SK; Scholl HPN;
    JAMA Ophthalmol; 2017 Jul; 135(7):696-703. PubMed ID: 28542693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential Disease Progression in Atrophic Age-Related Macular Degeneration and Late-Onset Stargardt Disease.
    Lindner M; Lambertus S; Mauschitz MM; Bax NM; Kersten E; Lüning A; Nadal J; Schmitz-Valckenberg S; Schmid M; Holz FG; Hoyng CB; Fleckenstein M;
    Invest Ophthalmol Vis Sci; 2017 Feb; 58(2):1001-1007. PubMed ID: 28288486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macular function and morphologic features in juvenile stargardt disease: longitudinal study.
    Testa F; Melillo P; Di Iorio V; Orrico A; Attanasio M; Rossi S; Simonelli F
    Ophthalmology; 2014 Dec; 121(12):2399-405. PubMed ID: 25097154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Asymmetric Inter-Eye Progression in Stargardt Disease.
    Lambertus S; Bax NM; Groenewoud JM; Cremers FP; van der Wilt GJ; Klevering BJ; Theelen T; Hoyng CB
    Invest Ophthalmol Vis Sci; 2016 Dec; 57(15):6824-6830. PubMed ID: 28002570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of stargardt disease using polarization-sensitive optical coherence tomography and fundus autofluorescence imaging.
    Ritter M; Zotter S; Schmidt WM; Bittner RE; Deak GG; Pircher M; Sacu S; Hitzenberger CK; Schmidt-Erfurth UM;
    Invest Ophthalmol Vis Sci; 2013 Sep; 54(9):6416-25. PubMed ID: 23882696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early-onset stargardt disease: phenotypic and genotypic characteristics.
    Lambertus S; van Huet RA; Bax NM; Hoefsloot LH; Cremers FP; Boon CJ; Klevering BJ; Hoyng CB
    Ophthalmology; 2015 Feb; 122(2):335-44. PubMed ID: 25444351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Natural History of the Progression of Atrophy Secondary to Stargardt Disease (ProgStar) Studies: Design and Baseline Characteristics: ProgStar Report No. 1.
    Strauss RW; Ho A; Muñoz B; Cideciyan AV; Sahel JA; Sunness JS; Birch DG; Bernstein PS; Michaelides M; Traboulsi EI; Zrenner E; Sadda S; Ervin AM; West S; Scholl HP;
    Ophthalmology; 2016 Apr; 123(4):817-28. PubMed ID: 26786511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ULTRAWIDEFIELD AUTOFLUORESENCE IN ABCA4 STARGARDT DISEASE.
    Klufas MA; Tsui I; Sadda SR; Hosseini H; Schwartz SD
    Retina; 2018 Feb; 38(2):403-415. PubMed ID: 28248825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular abnormalities in patients with Stargardt disease assessed with optical coherence tomography angiography.
    Battaglia Parodi M; Cicinelli MV; Rabiolo A; Pierro L; Bolognesi G; Bandello F
    Br J Ophthalmol; 2017 Jun; 101(6):780-785. PubMed ID: 27628426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ASSOCIATION BETWEEN GENOTYPE AND DISEASE PROGRESSION IN ITALIAN STARGARDT PATIENTS: A Retrospective Natural History Study.
    Di Iorio V; Orrico A; Esposito G; Melillo P; Rossi S; Sbordone S; Auricchio A; Testa F; Simonelli F
    Retina; 2019 Jul; 39(7):1399-1409. PubMed ID: 29642238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantification of peripapillary sparing and macular involvement in Stargardt disease (STGD1).
    Burke TR; Rhee DW; Smith RT; Tsang SH; Allikmets R; Chang S; Lazow MA; Hood DC; Greenstein VC
    Invest Ophthalmol Vis Sci; 2011 Oct; 52(11):8006-15. PubMed ID: 21873672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of segmentation density on spectral domain optical coherence tomography assessment in Stargardt disease.
    Velaga SB; Nittala MG; Jenkins D; Melendez J; Ho A; Strauss RW; Scholl HP; Sadda SR
    Graefes Arch Clin Exp Ophthalmol; 2019 Mar; 257(3):549-556. PubMed ID: 30613916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progression of Stargardt Disease as Determined by Fundus Autofluorescence in the Retrospective Progression of Stargardt Disease Study (ProgStar Report No. 9).
    Strauss RW; Muñoz B; Ho A; Jha A; Michaelides M; Cideciyan AV; Audo I; Birch DG; Hariri AH; Nittala MG; Sadda S; West S; Scholl HPN;
    JAMA Ophthalmol; 2017 Nov; 135(11):1232-1241. PubMed ID: 29049437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of estimated retinal atrophy progression in Stargardt macular dystrophy using spectral-domain optical coherence tomography.
    Strauss RW; Muñoz B; Wolfson Y; Sophie R; Fletcher E; Bittencourt MG; Scholl HP
    Br J Ophthalmol; 2016 Jul; 100(7):956-962. PubMed ID: 26568636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morpho-functional correlation of fundus autofluorescence in Stargardt disease.
    Parodi MB; Iacono P; Triolo G; La Spina C; Zucchiatti I; Cicinelli MV; Borrelli E; Manitto MP; Martina E; Bandello F
    Br J Ophthalmol; 2015 Oct; 99(10):1354-9. PubMed ID: 25837607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Foveal sparing in Stargardt disease.
    van Huet RA; Bax NM; Westeneng-Van Haaften SC; Muhamad M; Zonneveld-Vrieling MN; Hoefsloot LH; Cremers FP; Boon CJ; Klevering BJ; Hoyng CB
    Invest Ophthalmol Vis Sci; 2014 Oct; 55(11):7467-78. PubMed ID: 25324290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.